HOME >> BIOLOGY >> NEWS
Yale licenses potential anti-HIV agent to Oncolys BioPharma of Japan

New Haven, Conn. - Yale University today announced that it has concluded a license agreement granting Oncolys BioPharma, Inc. of Tokyo the global exclusive right for clinical and business development of a novel compound for the treatment of HIV.

A patent application has been submitted by Yale for 2',3'-Didehydro-3'-Deoxy-4'-Ethynylthymidine, or Ed4T, a compound with a new and potentially effective anti-HIV clinical treatment.

Ed4T is a thymidine analogue that blocks HIV-1 reverse transcriptase, the enzyme that is essential for viral replication. The compound was discovered and developed jointly by Professor Masanori Baba of Kagoshima University and Professor Hiromichi Tanaka of Showa University in Japan, and Yung-Chi Cheng, the Henry Bronson Professor of Pharmacology at Yale University School of Medicine.

"This license agreement was possible because Yale has shown keen appreciation of our corporate philosophy -- pharmaceutical development creating timely remedies for maximum patient relief," said Yasuo Urata, President and CEO of Oncolys BioPharma. "We will give this project our concentrated effort so that patients worldwide can have the benefit of 'Ed4T'as soon as possible." Pre-clinical studies have already begun and Oncolys BioPharma will accelerate the studies with a target of initiating Phase I/II clinical trials in 2008.

An estimated 20 million people worldwide have died from AIDS and 40.3 million are infected with the virus. In 2004, a reported 1,000 patients in Japan were infected -- and the numbers are rapidly increasing.

"Yale is very proud of the contribution it makes to fighting the HIV pandemic though discovery of novel antiviral drugs," stated E. Jonathan Soderstrom, Managing Director of the Yale Office of Cooperative Research, which is responsible for licensing technologies on behalf of Ya
'"/>

Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
27-Jun-2006


Page: 1 2 3

Related biology news :

1. University of Colorado licenses two influenza virus detection discoveries to Quidel Corp.
2. Rensselaer licenses microscope technology to Thorlabs
3. Columbia University licenses next-generation DNA sequencing technology
4. Case Western Reserve University licenses methoxyamine to Tracon
5. Mount Sinai School of Medicine licenses avian flu vaccine to Avimex
6. Bayer HealthCare licenses Genomatix for microarray analysis
7. Isotron licenses ORNL cancer treatment technology
8. IC-medtech licenses promising cancer therapeutic from Summa Health System
9. UCF research links proteins, stem cells and potential Alzheimers treatment
10. Picky eating potentially perilous for bats
11. Scientists take next step in understanding potential target for ovarian cancer treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2017)... , May 5, 2017 RAM ... announced a new breakthrough in biometric authentication based ... quantum mechanical properties to perform biometric authentication. These new ... semiconductor material created by Ram Group and its ... entertainment, transportation, supply chains and security. Ram Group ...
(Date:4/13/2017)... 2017 UBM,s Advanced Design and Manufacturing event ... emerging and evolving technology through its 3D Printing and ... alongside the expo portion of the event and feature ... focused on trending topics within 3D printing and smart ... event will take place June 13-15, 2017 at the Jacob ...
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s Medical ... place on 7th and 8th June 2018 in San Francisco, CA. The Summit brings ... well as several distinguished CEOs, board directors and government officials from around the world ...
(Date:10/11/2017)... Georgia (PRWEB) , ... October 11, 2017 , ... Disappearing ... taking the lives of over 5.5 million people each year. Especially those living in ... greenovative startup Treepex - based in one of the most pollution-affected countries globally - ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... 2017 SomaGenics announced the receipt of a ... RealSeq®-SC (Single Cell), expected to be the first commercially ... microRNAs) from single cells using NGS methods. The NIH,s ... accelerate development of approaches to analyze the heterogeneity of ... techniques for measuring levels of mRNAs in individual cells ...
Breaking Biology Technology:
Cached News: